Price $35.25 |
Market Cap
1.2B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.19
|
P/S
6.14
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-8.7K
|
FCF
-0.4
|
|
Op. Margin
-9.30%
|
Net Margin
-10.90%
|
ROE
-12.80%
|
ROI
-12.00%
|
|
ROA
-7.50%
|
EPS Growth
39.10%
|
Current Ratio
2.6
|
Debt/Equity
22.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Civitas Solutions Inc (CIVI) | $14.65 | - | - | 574.2M | Strong Buy |
| Aerpio Pharmaceuticals Inc (ARPO) | $3.39 | - | - | 141.2M | Strong Buy |
| American Renal Associates Hold (ARA) | $20.11 | - | - | 720.1M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.93 | - | - | 72.7M | Strong Buy |
| Micron Solutions Inc (MICR) | $3.60 | - | - | 10.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
